Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes

Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes

Abstract Background The objective of study was to determine the effect of anthracycline dose reduction and chemotherapy delays on 5-year overall survival in patients with stage I-III breast cancer, to establish the impact of molecular subtypes on the anthracycline modification effects and to analyze...

Full description

Bibliographic Details
Main Authors: Sigita Liutkauskiene, Saulius Grizas, Kristina Jureniene, Jorune Suipyte, Akvile Statnickaite, Elona Juozaityte
Format: Article
Language:English
Published: BMC 2018-04-01
Series:BMC Cancer
Subjects:
Breast cancer
Chemotherapy scheme modifications
Molecular subtypes
Overall survival
Online Access:http://link.springer.com/article/10.1186/s12885-018-4365-y

Internet

http://link.springer.com/article/10.1186/s12885-018-4365-y

Similar Items